SunTrust Downgrades Sarepta Therapeutic (SRPT) to Neutral
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $17.97 --0%
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 15
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 15
Join SI Premium – FREE
SunTrust Robinson Humphrey downgraded Sarepta Therapeutic (NASDAQ: SRPT) from Buy to Neutral with a price target of $33 (unchanged).
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $34.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Ameris Bancorp (ABCB) to Market Perform
- Raymond James Upgrades FirstSun Capital Bancorp (FSUN) to Strong Buy
- FDA accepts Sarepta's applications to convert two DMD drugs to full approval
Create E-mail Alert Related Categories
DowngradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
